SEC 13F Intelligence

Managers / Q2 2024 · view latest →

HighVista Strategies LLC

CIK 0001335325 · 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116 · 617-406-6500

Reported Value
$274M
Q2 2024
Positions
138
Filings on Record
30
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Highvista Strategies LLC reported $274M in U.S.-listed holdings across 138 positions for Q2 2024.

Its largest position, DBC, represents 12.2% of the portfolio.

Compared with Q1 2024, the fund opened 34 new positions and exited 28.

Portfolio Metrics

Turnover
+25.0%
vs prior filed quarter
Top-10 Concentration
+29.4%
share of reported value
Largest Position
+12.2%
Invesco Db Commdy Indx Trck
New / Exited
34 / 28
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $116MQ4 ’18Q1 ’19: $123MQ2 ’19: $195MQ3 ’19: $147MQ4 ’19: $132MQ4 ’19Q1 ’20: $108MQ2 ’20: $121MQ3 ’20: $137MQ4 ’20: $157MQ4 ’20Q1 ’21: $135MQ2 ’21: $141MQ3 ’21: $151MQ4 ’21: $126MQ4 ’21Q1 ’22: $157MQ2 ’22: $166MQ3 ’22: $175MQ4 ’22: $168MQ4 ’22Q1 ’23: $123MQ2 ’23: $219MQ3 ’23: $216MQ4 ’23: $276MQ4 ’23Q1 ’24: $280MQ2 ’24: $274MQ3 ’24: $290MQ4 ’24: $269MQ4 ’24Q1 ’25: $260MQ2 ’25: $272MQ3 ’25: $408MQ4 ’25: $388MQ4 ’25Q1 ’26: $362Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 69.0%ETP: 12.8%Other: 9.2%ADR: 8.4%REIT: 0.7%
  • Common Stock · 69.0% · $189M
  • ETP · 12.8% · $35M
  • Other · 9.2% · $25M
  • ADR · 8.4% · $23M
  • REIT · 0.7% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HCP2EURHASHICORP INCNEW+130.2K130.2K+$4M$4M
CTLTEURCATALENT INCNEW+75.6K75.6K+$4M$4M
ETRNUSDEQUITRANS MIDSTREAM CORPNEW+310.0K310.0K+$4M$4M
TEVATEVA PHARMACEUTICAL INDS LTDNEW+136.5K136.5K+$2M$2M
CRBPCORBUS PHARMACEUTICALS HLDGSNEW+38.8K38.8K+$2M$2M
ADBEADOBE INCNEW+3.1K3.1K+$2M$2M
PFEPFIZER INCNEW+60.3K60.3K+$2M$2M
KINIKSA PHARMACEUTICALS INTLNEW+88.7K88.7K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DBCINVESCO DB COMMDY INDX TRCKhistory →UNIT12.19%$33M1.44M
2IM8NINSMED INChistory →COM PAR $.013.10%$8M126.8K
3MERUS N VCOM2.52%$7M116.7K
4CRMSALESFORCE INChistory →COM1.99%$5M21.2K
5AXSMAXSOME THERAPEUTICS INChistory →COM1.83%$5M62.2K
6HCP2EURHASHICORP INChistory →COM CL A1.60%$4M130.2K
7HESHESS CORPhistory →COM1.56%$4M28.9K
8CTLTEURCATALENT INChistory →COM1.55%$4M75.6K
9JNPJUNIPER NETWORKS INChistory →COM1.53%$4M114.7K
10AKXANSYS INChistory →COM1.50%$4M12.8K
11MSFTMICROSOFT CORPhistory →COM1.50%$4M9.2K
12ETRNUSDEQUITRANS MIDSTREAM CORPhistory →COM1.47%$4M310.0K
13CEREVEL THERAPEUTICS HLDNG ICOM1.45%$4M97.2K
14ACIALBERTSONS COS INChistory →COMMON STOCK1.36%$4M188.8K
15AMEDAMEDISYS INChistory →COM1.32%$4M39.3K
16AMZNAMAZON COM INChistory →COM1.27%$3M18.0K
17INTUINTUIThistory →COM1.17%$3M4.9K
18APGEAPOGEE THERAPEUTICS INChistory →COM1.13%$3M78.9K
19BKNGBOOKING HOLDINGS INChistory →COM1.10%$3M757
20ARGXARGENX SEhistory →SPONSORED ADR1.04%$3M6.6K
21XENEXENON PHARMACEUTICALS INChistory →COM1.04%$3M72.7K
22ACLXGBXARCELLX INChistory →COMMON STOCK1.03%$3M51.0K
23X0M1XOMA CORP DELhistory →COM NEW1.03%$3M118.9K
24INDIVIOR PLCORD1.02%$3M178.8K
25ELVNENLIVEN THERAPEUTICS INChistory →COM1.02%$3M119.8K
26XPOXPO INCCOM0.99%$3M25.5K
27OLMAOLEMA PHARMACEUTICALS INCCOM0.98%$3M247.9K
28SYRESPYRE THERAPEUTICS INCCOM NEW0.98%$3M113.5K
29VRDNVIRIDIAN THERAPEUTICS INCCOM0.94%$3M198.5K
30BCYCBICYCLE THERAPEUTICS PLCSPONSORED ADS0.94%$3M127.3K
31CAPRI HOLDINGS LIMITEDSHS0.94%$3M77.7K
32PCVXVAXCYTE INCCOM0.89%$2M32.3K
33COGTCOGENT BIOSCIENCES INCCOM0.87%$2M281.1K
34VVISA INCCOM CL A0.86%$2M8.9K
35FISVFISERV INCCOM0.85%$2M15.6K
36CARTMAPLEBEAR INCCOM0.82%$2M69.7K
37TEVATEVA PHARMACEUTICAL INDS LTDSPONSORED ADS0.81%$2M136.5K
38NUVLNUVALENT INCCOM0.80%$2M28.7K
39GOOGALPHABET INCCAP STK CL C0.77%$2M11.4K
40TMUST-MOBILE US INCCOM0.77%$2M11.9K
41METAMETA PLATFORMS INCCL A0.75%$2M4.1K
42PTCPTC INCCOM0.70%$2M10.6K
43SWTXUSDSPRINGWORKS THERAPEUTICS INCCOM0.70%$2M51.0K
44MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD0.68%$2M42.2K
45SEAGATE TECHNOLOGY HLDNGS PLORD SHS0.67%$2M17.8K
46AUTLAUTOLUS THERAPEUTICS PLCSPON ADS0.66%$2M518.8K
47TVTXTRAVERE THERAPEUTICS INCCOM0.66%$2M219.4K
48EQREQUITY RESIDENTIALSH BEN INT0.66%$2M25.9K
49KROSKEROS THERAPEUTICS INCCOM0.65%$2M39.2K
50WDCWESTERN DIGITAL CORP.COM0.65%$2M23.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$362M156May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$388M145Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$408M148Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$272M146Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$260M148May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$269M137Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$290M142Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$274M138Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$280M131May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$276M126Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$216M132Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$219M134Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$123M108May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$168M105Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$175M113Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$166M110Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$157M86May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$126M69Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$151M127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$141M116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$135M125May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$157M117Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$137M113Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$121M100Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$108M65May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$132M119Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$147M126Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$195M108Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$123M112May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$116M113Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • HighVista Private Capital Management LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.